2017
DOI: 10.26717/bjstr.2017.01.000360
|View full text |Cite
|
Sign up to set email alerts
|

Small Size Nanosilver Multi Organ Toxicity: A Higher Dose Negative Response in In-Vivo and In-Vitro Experimental Application

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 11 publications
0
2
0
Order By: Relevance
“…AgNPs have been shown to be extremely toxic in small dimension (less than 20 nm), with faster rates of Ag dissolution, but teratogenic in bigger size and larger doses. Additionally, AgNPs produce various toxogenic responses [[53], [54], [55]], also triggering organ toxicity and inflammatory responses after repeated oral administration in vivo [56]. However, despite different exposure routes and animal species have been tested, to deeply comprehend AgNPs kinetics, tissue distribution and overall toxicity [17], the toxicological data coming from in vivo studies are still contentious and need to be cautiously interpreted since high unrealistic doses have been often employed.…”
Section: Introductionmentioning
confidence: 99%
“…AgNPs have been shown to be extremely toxic in small dimension (less than 20 nm), with faster rates of Ag dissolution, but teratogenic in bigger size and larger doses. Additionally, AgNPs produce various toxogenic responses [[53], [54], [55]], also triggering organ toxicity and inflammatory responses after repeated oral administration in vivo [56]. However, despite different exposure routes and animal species have been tested, to deeply comprehend AgNPs kinetics, tissue distribution and overall toxicity [17], the toxicological data coming from in vivo studies are still contentious and need to be cautiously interpreted since high unrealistic doses have been often employed.…”
Section: Introductionmentioning
confidence: 99%
“…"Dziendzikowska" [35] suggested that the liver is the first line of defense against NPs, for that the deposition of the non-biodegradable nanoparticles are likely to occur. Although the amount of these particles is translocated to other organs like the kidney and spleen [36,37]. An accumulation of AgNPs after intraperitoneal exposure in body organs mostly the liver and kidneys, were observed by Razooki [38].…”
Section: Bioaccumulation Studymentioning
confidence: 95%